pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Monoclonal Antibody · news · pharmadog
← back to Monoclonal Antibody
News · Monoclonal Antibody
555
stories
May 4, 26
STAT+: Pump the brakes on AI, buddy; and deposition deadlock
stat
May 4, 26
UCB to acquire maker of antibody treatments for autoimmune diseases
stat
May 4, 26
UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases
biopharma dive
May 1, 26
Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook
biopharma dive
May 1, 26
J&J axes pair of CAR-T therapies for lymphoma, citing evolving market
endpoints
May 1, 26
‘Forever chemicals’ in baby formula? Scientists unpack FDA results
stat
May 1, 26
Two biotechs raise a combined $556M in latest spurt of IPOs
biopharma dive
Apr 29, 26
Pfizer earns positive Phase 3 in multiple myeloma; ICON overstated revenue
endpoints
Apr 29, 26
FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
biopharma dive
Apr 28, 26
BeOne Medicines licenses trispecific antibody targeting PD-1, CTLA-4 and VEGF
endpoints
Apr 27, 26
Oruka surges as long-acting psoriasis drug shows early promise
biopharma dive
Apr 27, 26
Compass Therapeutics unveils key secondary endpoint results from pivotal biliary tract cancer trial
endpoints
Apr 22, 26
An ‘AI scientist’ can tackle drug R&D. What does that mean for pharma?
biopharma dive
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Foghorn cuts workforce by 40%; BioMarin drops 117 roles
fiercebiotech
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: KymaThera corrals $80M; RougeTx lifts off with $58M
fiercebiotech
← prev
page 19 of 19
next →
